The Port of Everett’s south terminal is the preferred site for construction of the new pontoons for the Hood Canal Bridge, the state Department of Transportation said Thursday. The work was started in Clallam County but was halted when officials discovered American Indian bones and artifacts. Three new sites, including Everett, will be studied. Port director John Mohr said he’s unsure of the number of jobs the project would create or even if the port would want the pontoon project. “We’re very fortunate in that there are a lot of good things happening right now at the marine terminals,” he said. “It’s great to have options.”
Martha Stewart goes home today
Alderson, W. Va., says goodbye today to its favorite convicted felon. Martha Stewart leaves prison today to begin serving the next phase of her sentence, five months of house arrest at her $16 million Bedford, N.Y., estate, about 550 miles away.
Boeing stock hits three-year high
The Boeing Co.’s stock rose nearly 4 percent to a 31/2-year high Thursday, climbing back to a level not reached since the 2001 terrorist attacks sent airplane buyers into a deep slump. The increase was attributed to general optimism about the airlines’ recovery and a bullish report from a Wall Street brokerage. Shares in the company increased $2.12 to $57.42, an increase of 10.9 percent so far this year.
Quinton merger prompts lawsuit
Just days after Bothell-based Quinton Cardiology Systems and Cardiac Science Inc. of Irvine, Calif., announced plans to merge, a class-action lawsuit has been filed on behalf of Cardiac shareholders. Under the merger terms, they would receive one-tenth of a share of the newly combined company, while Quinton shareholders would receive more than seven-tenths of a share for each share they now own. The lawsuit calls those terms grossly unfair.
Bellevue biotech moves to Bothell
Biotech company JBNI Inc., which develops and distributes nature-based medicines, has moved its headquarters from Bellevue to Bothell’s Canyon Park area. The firm, which signed a five-year lease, recently received federal approval to begin clinical trials of an asthma treatment called Azmazin.
From Herald staff
and news services
Talk to us
> Give us your news tips.
> Send us a letter to the editor.
> More Herald contact information.
